MHRA Drug Safety Update – July 2018

MHRA Drug Safety Update – July 2018

July 20, 2018

Date issued: 17th July 2018

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 11, Issue 12, July 2018) has been published and includes articles on:

  • pressurised metered dose inhalers (pMDI): risk of airway obstruction from
    aspiration of loose objects;
  • eltrombopag (Revolade): reports of interference with bilirubin and creatinine test
    results; and
  • medicines taken during pregnancy: please report suspected adverse drug reactions, including in the baby or child, on a Yellow Card.

To see the latest MHRA Drug Safety Update in full, visit the website.

Posted in:

More Latest News >

Shortage Notice: Salbutamol 2mg/5ml syrup

GlaxoSmithKline (GSK) and Pinewood, the manufacturers of Salbutamol 2mg/5ml syrup, are currently experiencing temporary disruptions. GSK, the main supplier of Salbutamol...